Tag: biotechnology
-
Late-Stage Covid-19 Vaccine Trial Underway in U.S.
Global drug maker AstraZeneca is starting its late-stage Covid-19 vaccine clinical trial in the U.S., with a vow not to cut corners in its processes.
-
Food Allergy Biotech Acquired for $2.6B
Aimmune Therapeutics Inc., a developer of food allergy drugs, was acquired today by global consumer products company Nestlé for $2.6 billion.
-
Infographic – Biotech Index Cruising in High Range
Looking back to May shows that NBI has largely settled in to the 4,000 to 4,500 range, without volatile swings in either direction.
-
Engineered Mosquitoes Approved for Disease Control
In an apparent end to a long-running dispute, authorities in the Florida Keys approved a field trial of engineered mosquitoes to control tropical diseases.
-
DoD Funding Variable Covid-19 Vaccine Technology
The U.S. Department of Defense is funding work on a Covid-19 vaccine platform that can adjust its formula to protect against future mutations in the virus.
-
Vaccine Blocks Covid-19 Infections in Animal Tests
An experimental vaccine shows in challenge tests with monkeys it protects against Covid-19 infections in nose, throat, and airways.
-
Biotechs, Univ. Labs Partner on Covid-19 Combo Therapy
Two biotechnology companies are developing a Covid-19 treatment that combines engineered antibodies and natural killer immune system cells.
-
Sanofi Acquires Immune Disease Biotech in $3.7B Deal
A developer of small-molecule therapies for autoimmune diseases, including multiple sclerosis, and other immune disorders is being acquired by Sanofi.
-
Start-Up Developing Microbial Cancer Detection Tests
A new company, spun off from university biomedical engineering labs, is creating early cancer diagnostics by analyzing microbial genetics in simple blood samples.
-
Small Biz Grant Advances Neuro Protection Drugs
An NIH award to a biotechnology company funds discovery of drugs that protect brain cells from degenerative disorders like Alzheimer’s disease.